Vontobel Holding Ltd. trimmed its position in CVS Health Co. (NYSE:CVS – Get Rating) by 4.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 298,023 shares of the pharmacy operator’s stock after selling 12,778 shares during the quarter. Vontobel Holding Ltd.’s holdings in CVS Health were worth $28,902,000 as of its most recent SEC filing.
Other institutional investors have also recently modified their holdings of the company. SRS Capital Advisors Inc. raised its stake in shares of CVS Health by 105.8% in the third quarter. SRS Capital Advisors Inc. now owns 284 shares of the pharmacy operator’s stock worth $27,000 after purchasing an additional 146 shares during the last quarter. Karp Capital Management Corp purchased a new position in shares of CVS Health in the third quarter worth about $30,000. Coston McIsaac & Partners purchased a new position in shares of CVS Health in the second quarter worth about $34,000. Moisand Fitzgerald Tamayo LLC raised its stake in shares of CVS Health by 63.6% in the third quarter. Moisand Fitzgerald Tamayo LLC now owns 368 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 143 shares during the last quarter. Finally, Win Advisors Inc. raised its stake in shares of CVS Health by 60.1% in the second quarter. Win Advisors Inc. now owns 405 shares of the pharmacy operator’s stock worth $38,000 after purchasing an additional 152 shares during the last quarter. 77.29% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on CVS. TheStreet upgraded CVS Health from a “c+” rating to a “b” rating in a research report on Friday, November 25th. Raymond James reduced their price target on CVS Health from $120.00 to $115.00 in a research report on Sunday, November 6th. Credit Suisse Group lifted their price target on CVS Health from $117.00 to $125.00 and gave the company an “outperform” rating in a research report on Monday, November 21st. Wells Fargo & Company reduced their price target on CVS Health from $106.00 to $101.00 and set an “equal weight” rating for the company in a research report on Tuesday, January 3rd. Finally, The Goldman Sachs Group reduced their price target on CVS Health from $128.00 to $113.00 and set a “buy” rating for the company in a research report on Thursday, November 3rd. Three analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $119.13.
CVS Health Price Performance
CVS Health (NYSE:CVS – Get Rating) last issued its quarterly earnings results on Wednesday, November 2nd. The pharmacy operator reported $2.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.99 by $0.10. The firm had revenue of $81.16 billion for the quarter, compared to analyst estimates of $76.53 billion. CVS Health had a return on equity of 15.56% and a net margin of 1.00%. On average, equities analysts forecast that CVS Health Co. will post 8.63 earnings per share for the current fiscal year.
CVS Health Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, February 1st. Stockholders of record on Friday, January 20th will be paid a $0.605 dividend. The ex-dividend date of this dividend is Thursday, January 19th. This is a positive change from CVS Health’s previous quarterly dividend of $0.55. This represents a $2.42 dividend on an annualized basis and a dividend yield of 2.79%. CVS Health’s payout ratio is currently 102.98%.
Insider Transactions at CVS Health
In other CVS Health news, EVP Thomas M. Moriarty sold 137,466 shares of the business’s stock in a transaction on Thursday, December 15th. The stock was sold at an average price of $98.36, for a total transaction of $13,521,155.76. Following the transaction, the executive vice president now owns 608,129 shares of the company’s stock, valued at $59,815,568.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.69% of the company’s stock.
CVS Health Profile
CVS Health Corp. engages in the provision of healthcare services. It operates through the following segments: Pharmacy Services, Retail or Long-Term Care, Health Care Benefits, and Corporate/Other. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long-Term Care segment includes the sale of prescription drugs and an assortment of health and wellness products, and general merchandise.
- Get a free copy of the StockNews.com research report on CVS Health (CVS)
- Intuit Is About To Make a Move, But Which Way?
- 3 Late January Earnings Plays With Pop Potential
- Low-Priced Stocks Still Paying Dividends
- Why is the Chipotle Stock Price Surging This Week?
- Is the Northrop Grumman Selloff an Opportunity?
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.